An Economic Evaluation of Bupivacaine Plus Fentanyl Versus Ropivacaine Alone for Patient-Controlled Epidural Analgesia After Total-Knee Replacement Procedure
| Autor: | Supranee Puangchan, Saipin Muangman, Supinya Tiviraj, Pattada Immark, Chulaluk Komoltri, Shusee Visalyaputra, Siriporn Pitimana-aree |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Male
medicine.medical_specialty Visual analogue scale Cost effectiveness medicine.drug_class Cost-Benefit Analysis medicine.medical_treatment Fentanyl Postoperative Complications Double-Blind Method medicine Humans Ropivacaine Prospective Studies Anesthetics Local Arthroplasty Replacement Knee Aged Pain Measurement Bupivacaine Pain Postoperative Local anesthetic business.industry Analgesia Patient-Controlled General Medicine Amides Arthroplasty Anesthetics Combined Surgery Analgesia Epidural Anesthesiology and Pain Medicine Patient Satisfaction Anesthesia Vomiting Female medicine.symptom business Anesthetics Intravenous medicine.drug |
| Zdroj: | Regional Anesthesia and Pain Medicine. 30:446-451 |
| ISSN: | 1098-7339 |
| Popis: | Background and Objectives Total-knee replacement (TKR) surgery is one of the most painful orthopedic procedures after surgery. Opioid has been commonly combined with a local anesthetic to improve the quality of pain relief, but the treatment has opioid-related side effects. This study compared the cost effectiveness of patient-controlled epidural analgesia (PCEA) with 0.0625% bupivacaine plus fentanyl (BF) 3 μg/mL versus 0.15% ropivacaine alone (R) during the first 48 hours after TKR procedure. Methods This prospective randomized double-blined study was performed on 70 patients who underwent unilateral TKR procedure and received either BF or R after surgery. Visual analog scale (VAS) pain score at rest and upon movement, side effects, and cost of treatment were compared. Results Overall pain at rest and upon movement between groups was not significantly different (P = 0.58, 95% CI = 4.4 to −7.8 and P = 0.8, 95% CI = 6.4 to −8.2, respectively). Patients in the BF group experienced more pruritus and had more vomiting episodes than those in the R group (P = .015), whereas no difference occurred in other side effects. Nevertheless, patient satisfaction with pain management was higher in the BF group compared with that in the R group. In addition, pain treatment with bupivacaine and fentanyl was 18% less costly compared with ropivacaine alone. Conclusions Considering the economic evaluation, we conclude that PCEA with 0.0625% bupivacaine plus fentanyl 3 μg/mL is more cost effective and provides more patient satisfaction than PCEA with ropivacaine alone. However, use of epidural ropivacaine alone causes fewer opioid-related side effects, particularly pruritus and vomiting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|